Grant: Engage Grants Program
University of Toronto
$25,000.00
A yeast surface display method tailored for nanobody display
EF 2013-14
Résumé
The poultry industry is a major player in Canada's economy, contributing more than ~$6.5B to Canada's GDP in 2011, with ~$350M in exports. Zoonotic bacteria infected poultry poses a serious challenge to human consumption, particularly now that zoonotic pathogens are becoming increasingly resistant to traditional antibiotics. AbCelex is a Canadian company developing single-domain antibodies, also known as nanobodies, against zoonotic bacteria. AbCelex nanobodies prevent pathogen colonization of poultry gut, resulting in healthier animals while reducing bacterial contamination of poultry meat for human consumption. A major barrier to nanobodies commercialization is the high cost associated with the production and purification processes. AbCelex is currently using a strategy for expression of nanobodies on the yeast surface that eliminates key purification steps, potentially overcoming a major barrier to market. However, existing methods for nanobody yeast surface display are far from ideal, as they result on surface expression only in ~20% of the cells, reducing efficiency and thus increasing cost. The collaboration between AbCelex and the laboratory of Prof. Sergio Peisajovich, at the University of Toronto, is aimed at engineering a novel yeast surface display method tailored for nanobodies to increase surface display levels to at least 80% of the cells, thus eliminating a major barrier to commercialization. Towards this goal, we will systematically screen all suitable yeast GPI-anchored cell wall proteins to identify optimal fusion partners to display nanobodies on the cell surface. AbCelex nanobody-based feed additive for prevention of bacterial contamination in poultry could provide a much-needed remedy to one of the poultry industry major problems. This proposal will substantially contribute to eliminate a major barrier to AbCelex nanobody commercialization, thus benefiting an important player in Canada's economy, while contributing to reduce foodborne diseases in Canada and around the world.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
451962-2013
Name nom
Peisajovich, Sergio
Department département
Cell and Systems Biology (St. George Campus)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5200
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Microbiology
Research subject fr
Microbiologie
Partie
1
Nb partie
1
Application title
A yeast surface display method tailored for nanobody display
Keyword
NSERC
Application summary
The poultry industry is a major player in Canada's economy, contributing more than ~$6.5B to Canada's GDP in 2011, with ~$350M in exports. Zoonotic bacteria infected poultry poses a serious challenge to human consumption, particularly now that zoonotic pathogens are becoming increasingly resistant to traditional antibiotics. AbCelex is a Canadian company developing single-domain antibodies, also known as nanobodies, against zoonotic bacteria. AbCelex nanobodies prevent pathogen colonization of poultry gut, resulting in healthier animals while reducing bacterial contamination of poultry meat for human consumption. A major barrier to nanobodies commercialization is the high cost associated with the production and purification processes. AbCelex is currently using a strategy for expression of nanobodies on the yeast surface that eliminates key purification steps, potentially overcoming a major barrier to market. However, existing methods for nanobody yeast surface display are far from ideal, as they result on surface expression only in ~20% of the cells, reducing efficiency and thus increasing cost. The collaboration between AbCelex and the laboratory of Prof. Sergio Peisajovich, at the University of Toronto, is aimed at engineering a novel yeast surface display method tailored for nanobodies to increase surface display levels to at least 80% of the cells, thus eliminating a major barrier to commercialization. Towards this goal, we will systematically screen all suitable yeast GPI-anchored cell wall proteins to identify optimal fusion partners to display nanobodies on the cell surface. AbCelex nanobody-based feed additive for prevention of bacterial contamination in poultry could provide a much-needed remedy to one of the poultry industry major problems. This proposal will substantially contribute to eliminate a major barrier to AbCelex nanobody commercialization, thus benefiting an important player in Canada's economy, while contributing to reduce foodborne diseases in Canada and around the world.